|
(BS883) |
SHISA3, a novel Wnt-dependent vascular signature in the developing heart |
| |
|
L. Priesmeier, D. Hartung, E. Schoger, F. Raad, D. Panakova, L. Zelarayán (Göttingen, Berlin) |
|
(BS884) |
Alternative splicing of pericentrin contributes to cell cycle control in cardiomyocytes |
| |
|
J. Steinfeldt, R. Becker, S. Vergarajauregui, F. Engel (Erlangen) |
|
(BS885) |
CRISPR-mediated activation of DLK1 to protect from heart failure phenotype in engineered human myocardium |
| |
|
N. Bader, A. Rika, E. Schoger, E. Buchholz, K. Toischer, L. Zelarayán, W.-H. Zimmermann, M. Tiburcy (Göttingen) |
|
(BS886) |
Developmental programs determine migratory and anti-fibrotic potential of human cardiac progenitors in heart regeneration |
| |
|
M. T. DeAngelis, C. M. Poch (München) |
|
(BS887) |
iPSC modelling of a patient-specific compound heterozygous TTN mutation causing cardiomyopathy |
| |
|
M. Pötsch, J. Qi, C. Mehnert, K. Guan (Dresden) |
|
(BS888) |
An integrated platform for molecular phenotypic analysis in DCM patient-specific iPSC-cardiomyocytes and CRISPR-Cas9-engineered controls as a diagnostic research tool in cardiovascular disease |
| |
|
A. Ebert, A. Malkovskiy, Y. Dai, N. Ignatyeva, J. Rajadas, G. Hasenfuß, for the study groups: AG31, AG 8, AG12 (Göttingen; Stanford, US) |
|
(BS889) |
Modeling diabetic cardiomyopathy in human induced pluripotent stem cell-derived cardiomyocytes to investigate direct cardiac effects of empagliflozin |
| |
|
M. Hasse, M. Schubert, S. Hansen, K. Guan (Dresden) |
|
(BS890) |
Hans-Jürgen-Bretschneider-Abstract-Preis:
Investigating the role of circular RNA, circREGEN, in cardiomyocyte proliferation and cardiac regeneration |
| |
|
S. Cushman, K. Xiao, D. LU, C. Bär, T. Thum (Hannover) |
|
(BS891) |
Stem-cell derived cardiomyocytes as a model to test IL1-beta inhibitor treatment of arrhythmias in severe COVID19 |
| |
|
F. Hohendanner, L. Semmler, S. Dimai, P. Lacour, H. Stachelscheid, A. S. Parwani, L.-H. Boldt, B. Pieske, F. Blaschke, F. R. Heinzel (Berlin) |
|
(BS892) |
Kardiale Regeneration des chronisch verletzten Herzens mittels künstlichem Herzgewebe |
| |
|
C. von Bibra, A. Shibamiya, B. Geertz, E. Querdel, M. Koehne, T. Stuedemann, T. Eschenhagen, F. Weinberger (Hamburg) |